Eva Morava-Kozicz

Quick facts

Phase 2 pipeline

• AVTX-801 · Genetics
  AVTX-801 is a gene therapy that aims to treat certain genetic disorders by replacing or repairing faulty genes.
• GlcNAc-GlcN

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Eva Morava-Kozicz portfolio CI brief
• Eva Morava-Kozicz pipeline updates RSS

Related

• Sector hub: All tracked pharma companies